Cinemark Holdings target price raised by Wedbush to $46 from $45
CNK•Wedbush raised its target price for Cinemark Holdings to $46 from $45.
Related News
Harmony Biosciences names Peter Anastasiou president and CEO effective Jan. 1, 2027
HRMY•
Ultragenyx Pharmaceutical target price cut to $22 from $25 by Wedbush
RARE•
Cerenome secures national in-network agreement with Aetna for CNSide tests
CNSY•
Litigation technology firm CS Disco Q3 revenue beats estimates on software growth
LAW•
Polar Power targets approximately $2 million in total annualized savings
POLA•